M Med Life S.A.
Med Life S.A., a private healthcare provider, provides integrated medical services through its clinics and hospitals in Romania. The company offers outpatient units and diagnostic imaging services; consultations with general practitioners and specialists; diagnostic imaging tests; day hospitalization services; hospitalization and surgical treatment services; medical and surgical specialties; maternal and child health dedicated services; and stem cell bank. It also provides laboratory services, such as biochemistry, pathological anatomy, molecular biology and genetics, hematology, immunology, microbiology, cytology, and toxicology; healthcare packages; a range of dental services; and fitness services and wellness facilities through the Sweat Concept network and Sanopass platform. In addition, the company is involved in the development of building projects; insurance broker; rental activities; and distribution and retail sale of pharmaceutical products in specialized stores. Med Life S.A. was incorporated in 1996 and is headquartered in Bucharest, Romania.…
Industry Peers
Medical Care FacilitiesKey Statistics
About Med Life (BVB: M)
›
Med Life (BVB: M) is listed on Bucharest Stock Exchange, where its shares trade in RON. It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 6,525 employees.
The shares were at 9.760 RON on 19 November 2026, up 14.3% over 52 weeks. Its 52-week range is 8.180 RON to 14.46 RON: the price is 32.5% below the high and 19.3% above the low.
Its market capitalisation is 5.18B RON.
Med Life reports return on equity of 5.9%, an operating margin of 4.9% and revenue up 11.2% year over year.
Its debt exceeds its cash by 1.87B RON, a debt-to-equity ratio of 4.04. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 5 analysts cover the stock, with an average rating of Hold; their mean price target of 11.53 RON is 18.2% above the current price. The next earnings report is expected on 20 November 2026.